BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response - - GEO DataSets

Summary

Format

Summary
Summary (text)
Unique Identifier List

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO Profiles

BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response

Analysis of prostate cancer (PC) cell lines (NCI-H660, VCaP, LNCaP, PC-3) treated with I-BET762 at 0.5uM or 10uM for 24hr. I-BET762 is a highly specific inhibitor of BET (bromodomain and extra-terminal) proteins. Results provide insight into molecular pathways regulated by I-BET762 treatment in PC.

Organism:: Homo sapiens

Type:: Expression profiling by array, count, 4 cell line, 3 dose sets

Platform:: GPL570
Series:: GSE56352
24 Samples

Download data: CEL

DataSet

Accession:: GDS4952

ID:: 4952

Analyze DataSet

GEO DataSets

Functional Genomics Studies

Result Filters

Send to:

Links from GEO Profiles

Supplemental Content

Important Links

Recent activity